Literature DB >> 20060112

Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS).

Roger Hart1, Dorota A Doherty, Robert J Norman, Stephen Franks, Jan E Dickinson, Martha Hickey, Deborah M Sloboda.   

Abstract

Polycystic ovarian syndrome (PCOS) is a common endocrine disorder in adolescents, with potentially significant lifelong consequences. This prospective study set out to determine if the investigators could derive a threshold value of antimullerian hormone (AMH) that would predict its presence according to two internationally recognized definitions using a simple measurement, avoiding more extensive and potentially more invasive investigations. The study failed to demonstrate, in a general adolescent population, that serum AMH is a reliable predictor of PCO morphology or for the presence of PCOS. Copyright (c) 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20060112     DOI: 10.1016/j.fertnstert.2009.11.002

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  35 in total

Review 1.  The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum.

Authors:  Robert L Rosenfield
Journal:  J Pediatr Adolesc Gynecol       Date:  2014-08-27       Impact factor: 1.814

Review 2.  Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood.

Authors:  David H Abbott; Fida Bacha
Journal:  Fertil Steril       Date:  2013-07       Impact factor: 7.329

Review 3.  Anti-Müllerian hormone as a marker of ovarian reserve: What have we learned, and what should we know?

Authors:  Akira Iwase; Tomoko Nakamura; Satoko Osuka; Sachiko Takikawa; Maki Goto; Fumitaka Kikkawa
Journal:  Reprod Med Biol       Date:  2015-11-23

Review 4.  Diagnosis and challenges of polycystic ovary syndrome in adolescence.

Authors:  Sophia E Agapova; Tamara Cameo; Aviva B Sopher; Sharon E Oberfield
Journal:  Semin Reprod Med       Date:  2014-04-08       Impact factor: 1.303

5.  Anti-Müllerian Hormone in Obese Adolescent Girls With Polycystic Ovary Syndrome.

Authors:  Joon Young Kim; Hala Tfayli; Sara F Michaliszyn; SoJung Lee; Alexis Nasr; Silva Arslanian
Journal:  J Adolesc Health       Date:  2016-12-18       Impact factor: 5.012

Review 6.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

7.  Different diagnostic power of anti-Mullerian hormone in evaluating women with polycystic ovaries with and without hyperandrogenism.

Authors:  Yi Li; Yun Ma; Xianghong Chen; Wenjun Wang; Yu Li; Qingxun Zhang; Dongzi Yang
Journal:  J Assist Reprod Genet       Date:  2012-08-11       Impact factor: 3.412

Review 8.  Nonhuman primate models of polycystic ovary syndrome.

Authors:  David H Abbott; Lindsey E Nicol; Jon E Levine; Ning Xu; Mark O Goodarzi; Daniel A Dumesic
Journal:  Mol Cell Endocrinol       Date:  2013-01-29       Impact factor: 4.102

9.  Anti-Mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents.

Authors:  Aviva B Sopher; Galina Grigoriev; Diana Laura; Tamara Cameo; Jodi P Lerner; R Jeffrey Chang; Donald J McMahon; Sharon E Oberfield
Journal:  J Pediatr Endocrinol Metab       Date:  2014-11       Impact factor: 1.634

10.  Assessment of the Role of the Anti-Mullerian Hormone, Luteinizing Hormone/Follicle Stimulating Hormone Ratio in the Diagnosis of Polycystic Ovary Syndrome in Sudanese Women.

Authors:  Hafza Tola; Mohammed Abbas; Elsir Abu Alhassan; Nassr Eldin Shrif; Mohammed Rida
Journal:  Open Access Maced J Med Sci       Date:  2018-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.